/
/
/

Lincoln Pharmaceuticals Profit & Loss

Consolidated
Standalone
Quarterly
Yearly
%
Name
Net Revenue
Other Income
Total Revenue
Total Expenditure
Operating Profit
Interest Expense
PBT
Net Profit
Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023Jun 2023Mar 2023Dec 2022Sep 2022Jun 2022Mar 2022Dec 2021Sep 2021Jun 2021Mar 2021Dec 2020Sep 2020Jun 2020Mar 2020Dec 2019Sep 2019Jun 2019Mar 2019Dec 2018Sep 2018Jun 2018Mar 2018Dec 2017Sep 2017Jun 2017Mar 2017Dec 2016Sep 2016Jun 2016Mar 2016Dec 2015Sep 2015Jun 2015Mar 2015Dec 2014Sep 2014Jun 2014Mar 2014Dec 2013Sep 2013Jun 2013Mar 2013Dec 2012Sep 2012
₹177 Cr₹187 Cr₹166 Cr₹163 Cr₹154 Cr₹168 Cr₹147 Cr₹161 Cr₹147 Cr₹142 Cr₹146 Cr₹156 Cr₹136 Cr₹112 Cr₹134 Cr₹141 Cr₹123 Cr₹103 Cr₹120 Cr₹127 Cr₹122 Cr₹80 Cr₹115 Cr₹126 Cr₹104 Cr₹78 Cr₹99 Cr₹113 Cr₹97 Cr₹79 Cr₹84 Cr₹103 Cr₹100 Cr₹67 Cr₹80 Cr₹90 Cr₹150 Cr₹121 Cr₹72 Cr₹75 Cr₹89 Cr₹120 Cr₹108 Cr₹95 Cr₹76 Cr₹79 Cr₹68 Cr₹78 Cr₹49 Cr₹67 Cr₹53 Cr₹56 Cr₹40 Cr₹60 Cr₹52 Cr₹55 Cr
₹24 Cr-₹4 Cr₹15 Cr₹7 Cr₹15 Cr-₹7 Cr₹9 Cr₹10 Cr₹10 Cr₹7 Cr₹11 Cr₹9 Cr₹8 Cr₹4 Cr₹6 Cr₹6 Cr₹6 Cr₹2 Cr₹3 Cr₹3 Cr₹2 Cr₹3 Cr₹73 L₹60 L₹2 Cr₹4 Cr₹3 Cr₹3 Cr₹1 Cr-₹87 L₹38 L₹4 Cr₹2 Cr₹86 L₹3 Cr₹3 Cr₹3 Cr₹21 L₹3 Cr₹3 Cr₹4 Cr₹9 Cr₹0₹0₹0₹0₹0₹0₹0₹0₹0₹0₹0₹0₹0₹0
₹202 Cr₹183 Cr₹181 Cr₹171 Cr₹169 Cr₹161 Cr₹156 Cr₹171 Cr₹158 Cr₹150 Cr₹157 Cr₹165 Cr₹143 Cr₹116 Cr₹140 Cr₹146 Cr₹130 Cr₹104 Cr₹123 Cr₹131 Cr₹124 Cr₹82 Cr₹115 Cr₹127 Cr₹106 Cr₹83 Cr₹102 Cr₹115 Cr₹98 Cr₹78 Cr₹85 Cr₹107 Cr₹102 Cr₹68 Cr₹83 Cr₹93 Cr₹153 Cr₹121 Cr₹75 Cr₹78 Cr₹93 Cr₹129 Cr₹108 Cr₹95 Cr₹76 Cr₹79 Cr₹68 Cr₹78 Cr₹49 Cr₹67 Cr₹53 Cr₹56 Cr₹40 Cr₹60 Cr₹52 Cr₹55 Cr
₹154 Cr₹166 Cr₹146 Cr₹142 Cr₹134 Cr₹145 Cr₹126 Cr₹136 Cr₹128 Cr₹127 Cr₹120 Cr₹127 Cr₹117 Cr₹98 Cr₹109 Cr₹114 Cr₹109 Cr₹87 Cr₹99 Cr₹100 Cr₹99 Cr₹66 Cr₹97 Cr₹98 Cr₹84 Cr₹72 Cr₹87 Cr₹90 Cr₹80 Cr₹70 Cr₹73 Cr₹85 Cr₹78 Cr₹59 Cr₹65 Cr₹76 Cr₹145 Cr₹118 Cr₹65 Cr₹65 Cr₹75 Cr₹118 Cr₹96 Cr₹85 Cr₹65 Cr₹72 Cr₹62 Cr₹67 Cr₹43 Cr₹62 Cr₹47 Cr₹51 Cr₹36 Cr₹53 Cr₹49 Cr₹50 Cr
₹52 Cr₹21 Cr₹39 Cr₹33 Cr₹39 Cr₹20 Cr₹33 Cr₹38 Cr₹33 Cr₹25 Cr₹41 Cr₹40 Cr₹28 Cr₹21 Cr₹33 Cr₹35 Cr₹23 Cr₹19 Cr₹26 Cr₹33 Cr₹27 Cr₹18 Cr₹21 Cr₹30 Cr₹24 Cr₹13 Cr₹16 Cr₹27 Cr₹20 Cr₹10 Cr₹14 Cr₹24 Cr₹26 Cr₹11 Cr₹19 Cr₹18 Cr₹10 Cr₹4 Cr₹12 Cr₹15 Cr₹19 Cr₹12 Cr₹13 Cr₹12 Cr₹11 Cr₹7 Cr₹6 Cr₹12 Cr₹7 Cr₹5 Cr₹7 Cr₹5 Cr₹5 Cr₹8 Cr₹3 Cr₹6 Cr
₹26 L₹27 L₹30 L₹23 L₹21 L₹37 L₹73 L₹35 L₹44 L₹50 L₹16 L₹39 L₹42 L₹1 Cr₹33 L₹14 L₹41 L₹57 L₹31 L₹20 L₹38 L₹58 L₹39 L-₹8 L₹67 L-₹56 L₹1 Cr₹58 L₹65 L₹79 L₹71 L₹2 Cr₹1 Cr₹94 L₹1 Cr₹1 Cr₹2 Cr₹1 Cr₹1 Cr₹2 Cr₹2 Cr₹4 Cr₹2 Cr₹2 Cr₹2 Cr₹3 Cr₹2 Cr₹2 Cr₹2 Cr₹3 Cr₹2 Cr₹48 L₹1 Cr₹2 Cr₹1 Cr₹1 Cr
₹48 Cr₹17 Cr₹35 Cr₹29 Cr₹35 Cr₹16 Cr₹29 Cr₹35 Cr₹29 Cr₹22 Cr₹38 Cr₹37 Cr₹25 Cr₹17 Cr₹31 Cr₹32 Cr₹21 Cr₹17 Cr₹24 Cr₹31 Cr₹25 Cr₹15 Cr₹18 Cr₹29 Cr₹21 Cr₹12 Cr₹13 Cr₹25 Cr₹18 Cr₹8 Cr₹11 Cr₹20 Cr₹23 Cr₹8 Cr₹16 Cr₹15 Cr₹7 Cr₹1 Cr₹9 Cr₹12 Cr₹15 Cr₹6 Cr₹10 Cr₹9 Cr₹8 Cr₹3 Cr₹4 Cr₹9 Cr₹4 Cr₹1 Cr₹4 Cr₹4 Cr₹3 Cr₹5 Cr₹1 Cr₹4 Cr
₹36 Cr₹12 Cr₹29 Cr₹20 Cr₹28 Cr₹12 Cr₹21 Cr₹26 Cr₹24 Cr₹19 Cr₹28 Cr₹28 Cr₹19 Cr₹13 Cr₹22 Cr₹24 Cr₹15 Cr₹11 Cr₹18 Cr₹23 Cr₹18 Cr₹13 Cr₹13 Cr₹21 Cr₹15 Cr₹9 Cr₹11 Cr₹19 Cr₹13 Cr₹9 Cr₹9 Cr₹15 Cr₹16 Cr₹7 Cr₹12 Cr₹11 Cr₹5 Cr₹1 Cr₹7 Cr₹9 Cr₹11 Cr₹4 Cr₹6 Cr₹7 Cr₹7 Cr₹2 Cr₹3 Cr₹7 Cr₹3 Cr₹77 L₹3 Cr₹3 Cr₹3 Cr₹5 Cr₹1 Cr₹3 Cr

Share Price Live Stats

Open (₹)627.00
Volume (₹)12,082.00
High (₹)631.00
Upper Circuit747.15
Low (₹)618.05
Lower Circuit498.15
Prev Close622.65
52W High (₹)770.00
Price622.95
52W Low (₹)440.00

Share Market Cap & Key Ratios Overview

M.Cap (₹)1247.65 Cr
Div. Yield (%)0.29
PE Ratio12.94
Debt to Equity0.00
Price to Book1.64
Book Value335.34
EPS (TTM)48.15
Face Value10.00
ROE (%)13.02

Stock Analysis (SWOT)

StrengthsWeaknessesOpportunitiesThreats
1. Premium insight available after login
2. Sign in to view full SWOT analysis
3. Unlock strengths, weaknesses, opportunities & threats
Sign in to view
Open a free Demat account in minutes to start investing and screening .

QVT

Quality
0/100-
Valuation
0/100-
Technical
0/100-
Sign in to view
Open a free Demat account in minutes to start investing and screening .

Peer Stocks

1 week
1 month
1 year
Name
SUNPHARMANSE
DIVISLABNSE
TORNTPHARMNSE
ZYDUSLIFENSE
CIPLANSE
LAURUSLABSNSE
LUPINNSE
MANKINDNSE
DRREDDYNSE
AUROPHARMANSE
LINCOLNNSE
LTP
1W Low
1W High
Market cap (₹)
1905.1-14.9 (-0.78%)
1902
1984.80
4,56,833Cr
9211.5-27.5 (-0.30%)
9087
9467
2,45,426Cr
4894-156 (-3.09%)
4885
5066
1,87,320Cr
1133.2-57.8 (-4.85%)
1125.10
1187
1,13,217Cr
1391.5-32 (-2.25%)
1376.70
1426.10
1,12,212Cr
1854.2-84.3 (-4.35%)
1811.70
1949
1,01,155Cr
2123-48.5 (-2.23%)
2118.10
2192
97,626Cr
2349.2-33.7 (-1.41%)
2341.20
2419.20
96,859Cr
1163.9-14.1 (-1.20%)
1154.40
1179.90
96,406Cr
1656.5+11.2 (0.68%)
1622.60
1717
93,614Cr
622.95+8 (1.30%)
603.35
631
1,248Cr

Key Highlights of Lincoln Pharmaceuticals Ltd’s P&L

In 2025-03-31, Lincoln Pharmaceuticals Ltd reported total revenue of ₹645.71Cr, compared with ₹614.97Cr in 2024-03-31, reflecting Lincoln Pharmaceuticals Ltd turnover.

Depreciation was ₹12.9Cr and finance costs were ₹1.88Cr in 2025-03-31

Profit Before Tax (PBT) has been ₹109.19Cr in 2025-03-31 as compared to ₹122.24Cr in 2024-03-31.

Net Profit (PAT) was ₹82.35Cr in 2025-03-31 compared with ₹93.3Cr in 2024-03-31.

Earnings per share (EPS) were ₹41.11 in 2025-03-31, compared with ₹46.58 in 2024-03-31.